Vanguard Group’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31M | Buy |
15,903,054
+505,234
| +3% | +$985K | ﹤0.01% | 2348 |
|
|
2025
Q1 | $27.1M | Sell |
15,397,820
-334,747
| -2% | -$589K | ﹤0.01% | 2363 |
|
|
2024
Q4 | $41.8M | Buy |
15,732,567
+4,913,820
| +45% | +$13.1M | ﹤0.01% | 2239 |
|
|
2024
Q3 | $24.8M | Buy |
10,818,747
+675,849
| +7% | +$1.55M | ﹤0.01% | 2486 |
|
|
2024
Q2 | $29.6M | Buy |
10,142,898
+2,608,750
| +35% | +$7.62M | ﹤0.01% | 2370 |
|
|
2024
Q1 | $27.4M | Buy |
7,534,148
+219,533
| +3% | +$799K | ﹤0.01% | 2441 |
|
|
2023
Q4 | $11M | Buy |
7,314,615
+18,457
| +0.3% | +$27.9K | ﹤0.01% | 2891 |
|
|
2023
Q3 | $9.78M | Buy |
7,296,158
+17,118
| +0.2% | +$22.9K | ﹤0.01% | 2896 |
|
|
2023
Q2 | $13.1M | Buy |
7,279,040
+76,574
| +1% | +$138K | ﹤0.01% | 2797 |
|
|
2023
Q1 | $12M | Sell |
7,202,466
-2,729,975
| -27% | -$4.53M | ﹤0.01% | 2845 |
|
|
2022
Q4 | $19.1M | Sell |
9,932,441
-2,712,010
| -21% | -$5.21M | ﹤0.01% | 2650 |
|
|
2022
Q3 | $28.3M | Buy |
12,644,451
+11,813
| +0.1% | +$26.5K | ﹤0.01% | 2471 |
|
|
2022
Q2 | $40.9M | Sell |
12,632,638
-299,822
| -2% | -$971K | ﹤0.01% | 2290 |
|
|
2022
Q1 | $68M | Buy |
12,932,460
+1,671,908
| +15% | +$8.79M | ﹤0.01% | 2144 |
|
|
2021
Q4 | $95.7M | Sell |
11,260,552
-641,975
| -5% | -$5.46M | ﹤0.01% | 2007 |
|
|
2021
Q3 | $118M | Buy |
11,902,527
+806,166
| +7% | +$8.01M | ﹤0.01% | 1901 |
|
|
2021
Q2 | $103M | Buy |
11,096,361
+4,139,205
| +59% | +$38.5M | ﹤0.01% | 1984 |
|
|
2021
Q1 | $72.7M | Buy |
+6,957,156
| New | +$72.7M | ﹤0.01% | 2116 |
|